Market Overview

Aviir, Inc.'s CEO Dr. Douglas Harrington to Deliver Facts, Broaden Understanding of Heart Disease at the Los Angeles Ultimate Women's Expo on Oct. 27


Heart disease, the leading killer of women in the U.S., is also a major cause of disability and bankruptcy, according to Dr. Harrington.

Irvine, CA (PRWEB) October 25, 2012

Dr. Douglas Harrington, CEO of Aviir Inc., will join a host of influential companies and experts at the Los Angeles Ultimate Women's Expo on Saturday, October 27 to discuss America's leading threat to women – Heart Disease. Dr. Harrington's lecture, “Everything You Ever Wanted to Know About Heart Disease But Were Afraid to Ask” will provide a higher level of insight into the disease and how women can empower themselves, improving their cardiovascular health. The speaking session, which begins at 12:30 PM, will be located in Exhibit Hall H in the SOUTH HALL at the LA Convention Center and is sponsored by GuardaHeart Foundation.

As CEO of Aviir, Inc., Dr. Harrington brings more than 25 years of experience in the commercialization of healthcare technology. Aviir, Inc. is an Irvine-based biotechnology company that develops innovative diagnostic and laboratory tests. Dr. Harrington's personal mission is to offer clarity to heart disease through reliable assessments and prevention.

The Ultimate Women's Expo seeks out some of the best seminar speakers around the world to participate in their event, which is held in several cities across the country.

GuardaHeart sponsors heart risk assessments through an on-going collaboration with Aviir. Aviir and GuardaHeart will be jointly exhibiting at booth's #1033-1041. The Guard A Heart foundation is a non-profit organization raising awareness of cardiovascular disease and the importance of each individual knowing their risk score.

“Heart Disease remains the nation's number one killer and a major cause of disability and bankruptcy,” commented Dr. Douglas Harrington. “Fortunately, it is largely preventable through lifestyle modification, which can reduce an individual's risk by as much as 80 percent,” said Dr. Harrington.

Dr. Harrington will also discuss an innovative blood test, developed through an Aviir/Stanford University cardiology collaboration, which identifies an individuals' cardiac risk in a five-year timeframe.

“This timeframe allows preventive measures to be implemented,” continued Dr. Harrington. “Our mission is to improve healthcare and encourage timely preventive strategies by providing this unique medical information.”

About Aviir, Inc.
Aviir was founded in 2005 by cardiologists and scientists from the Stanford University School of Medicine to focus on discovery, development and commercialization of innovative diagnostic tests. The biotechnology company specializes in developing proprietary diagnostic tests that will assist in identifying patients that are truly at high risk for the development of a cardiac event. Aviir's proprietary MIRisk and TruRisk assessments objectively identify, by a simple blood draw, individuals who are at a high risk of a cardiac event over the next five years. Aviir's CLIA laboratory (Irvine, CA) complements these novel tests with a wide range of additional tests for risk assessment and therapeutic monitoring of cardiovascular disease and related metabolic disorders – including pharmacogenomic and genetic tests. The company has adopted a unique clinical laboratory service model to provide physicians better diagnostic tools that improve cardiovascular health of their patients. The company is privately owned and funded by leading life science venture capital firms. Please visit for more information.

About Los Angeles Ultimate Women's Expo
The Ultimate Women's Expo unites thousands of women with the most respected companies and brands that provide valuable products and services designed to enrich the lives of women. Indulge with the very best Los Angeles has to offer in shopping, fashion, food, entertainment, cosmetics, health and wellness and travel. Expo hours are October 27 and 28 from 10:00 AM - 5:00 PM. For more information, visit:

For media inquiries, please contact: Dina Scaglione (949) 398-6320 dina.scaglione (at) aviir (dot) com

For Interviews at the Expo please contact:
Yvette Morales
YM & Associates
PR | Marketing | Branding | Business Development
California | New York
949.244.9769 | 310.499.0906 Fax
YMoralesY (at) YM-PR (dot) com
Twitter: @YMTheBevHillsPR

For the original version on PRWeb visit:

View Comments and Join the Discussion!